Study Title | Reference Drug | End point Parameters |
---|---|---|
Hepatoprotective activity using CCl4 induced rat / Mice model | Silymarin | SGOT, SGPT, Bilirubin, GGT, body weight, feed consumption & liver histology |
Hepatoprotective activity using Ethanol induced rat / Mice model | Silymarin | SGOT, SGPT, Bilirubin, GGT, body weight, feed consumption & liver histology |
Hepatoprotective activity using Paracetamol induced rat / Mice model | Silymarin | SGOT, SGPT, Bilirubin, GGT, body weight, feed consumption & liver histology |
Con-A induced Liver inflammation model in mice | Silymarin | SGOT, SGPT, Bilirubin, GGT, Serum Cytokines (TNF alpha & IFN gamma) liver histology |
Study Title | Reference Drug | End point Parameters |
---|---|---|
Aphrodisiac activity using mating behaviour test Male & Female Rats | Ashwagandha | No. of mounting, Intromission time & latency , Testosterone level , body weight , Etc… |
Erectile dysfunction: Isolated tissue preparation – Corpora cavernosa contraction test | Sildenafil Citrate | % Contarction & % Relaxation of CC tissue |
Study Title | Reference Drug | End point Parameters |
---|---|---|
Ex-vivo haemolysis assay using rabbit blood | SDS | % hemolysis |
Study Title | Reference Drug | End point Parameters |
---|---|---|
Determination MTD to select safe dose for efficacy studies using Mice | NA | % Body weight change, Mortality, Hematology & biochemistry |
Study Title | Reference Drug | End point Parameters |
---|---|---|
Phenyl hydrazine- induced anemia model using Rats | Fe sulphaste | Hb Level , complete heamatology & biochemistry |
Study Title | Reference Drug | End point Parameters |
---|---|---|
Nephroprotective Activity using Gentamycin induced rat model | — | Kidney function test, Histology of kidney, urinanalysis |
Study Title | Reference Drug | End point Parameters |
---|---|---|
L-NAME and High Fat Diet -induced cardiac abnormalities using rats | Atorvastatin + Captopril | Blood pressure, lipid profile, serum cytokines, histology of vital organs |
Study Title | Reference Drug | End point Parameters |
---|---|---|
Bleomycin induced lung fibrosis model in C57BL6 Mice | Pirfenidone | BALF – cytokine (IL1beta & TNF alpha) Lung biomarker (TGF beta, IL1beta) & Histology of Lung |
Pollutant (PM2.5/Ovalbumin/LPS) induced lung inflammation model in BALB/c Mice | — | Cytokine (TNF alpha, IL6, IgE, etc..) level in BALF & Lung, and histology of Lung |
Study Title | Reference Drug | End point Parameters |
---|---|---|
Cyclophosphmaide/pyrogallol induced immunosuppression model in rats | Levamizole | Sheep RBC -Titer Value, IFN gamma in serum, Heamogram |
Cyclophaophamide-Induced Thrombocytopenia in Sprague Dawley Rats | Papaya extract | Heamogram Platelet count Complete blood count, Hb |
Study Title | Reference Drug | End point Parameters |
---|---|---|
Anti-fatigue actvity using weight loaded swim endurance model in rats | — | Swimmimg time, Lactate level in blood, |
Study Title | Reference Drug | End point Parameters |
---|---|---|
Sodium selenite -induced cataract model in young rats | Triphala drops | Cataract grade, Opacity score of isolated lens, Slit lamp examination |